HomeSGMT • NASDAQ
add
Sagimet Biosciences Inc
Previous close
$3.31
Day range
$3.19 - $3.37
Year range
$1.73 - $7.38
Market cap
103.67M USD
Avg Volume
598.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.86M | 126.56% |
Net income | -18.18M | -174.19% |
Net profit margin | — | — |
Earnings per share | -0.56 | -143.48% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 144.57M | -25.37% |
Total assets | 146.17M | -24.86% |
Total liabilities | 7.18M | 59.20% |
Total equity | 138.99M | — |
Shares outstanding | 32.20M | — |
Price to book | 0.77 | — |
Return on assets | -32.41% | — |
Return on capital | -33.68% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -18.18M | -174.19% |
Cash from operations | -14.54M | -134.15% |
Cash from investing | 3.41M | 13.77% |
Cash from financing | — | — |
Net change in cash | -11.12M | -110.94% |
Free cash flow | -8.16M | -67.75% |
About
Founded
2006
Headquarters
Website
Employees
14
